Owner Scorecard


← All companies ← PH Manual PHIN → ← PHAR Pharmaceuticals PRE →

PHAT, Phathom Pharmaceuticals Inc.

Pharmaceuticals consumer brand UnprofitableDistress / turnaround

We are a commercial-stage biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal, or GI, diseases.

VOQUEZNA is the only PCAB currently approved for marketing and sale in the United States.

Vonoprazan was originally developed by Takeda Pharmaceutical Company Limited, or Takeda, and is marketed in multiple countries outside the United States.

Latest annual: FY2025 10-K
PHAT · Phathom Pharmaceuticals Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$175M
+216.9% YoY
Vital signs · TTM, with 4-yr average
Revenue $205M 4-yr avg $58M
Gross margin 85% 4-yr avg 83%
Operating margin −47.1% 4-yr avg −8375.4%
Owner-earnings margin −48% 4-yr avg −6945%
Free cash flow margin −48% 4-yr avg −6997%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Unprofitable. No sustained operating profit across the record; an earnings multiple has nothing to rest on. What the record does show is revenue, the gross-margin trajectory, and the burn against the cash on hand. Distress / turnaround. Thin interest coverage, or operating cash burned against real debt, across the record. The balance sheet carries this situation; the debt schedule sets the clock.
What moves the needle
Operating margin has run around −502% through the cycle on a 86% gross margin, the operating line in the red even at its best — so the lever is whether the spending below the gross line can come down enough to clear a profit: revenue growth against the cost curve, and the cash runway until it does. The cash cycle has run negative through the cycle (a median of −78 days): the operation is paid before it pays, so working capital releases cash as the business grows rather than tying it up. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on going-concern doubt, set against the numbers in what the filing emphasizes, below.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2022–2025

realized figures from each filing · older years to the left
2022’222023’232024’242025’25TTMTTMMar 2026
Income statement
$0$682K$55M$175M$205MRevenueRevenue
76%86%87%85%Gross marginGross mgn
n/m526%160%117%SG&A / revenueSG&A/rev
n/m62%19%15%R&D / revenueR&D/rev
($172M)($167M)($277M)($160M)($97M)Operating incomeOp. inc.
n/m−502.2%−91.4%−47.1%Operating marginOp. mgn
($198M)($202M)($334M)($221M)($157M)Net incomeNet inc.
Cash flow & returns
($147M)($138M)($267M)($167M)($97M)Operating cash flowOp. cash
$620K$575K$795K$633K$566KDepreciationDeprec.
$26M$18M$43M$25M$31MWorking capital & otherWC & other
$1M$2M$135K$229K$272KCapexCapex
239.6%0.2%0.1%0.1%Capex / revenueCapex/rev
($147M)($138M)($267M)($167M)($98M)Owner earningsOwner earn.
n/m−483.1%−95.4%−47.7%Owner earnings marginOE mgn
($148M)($139M)($267M)($167M)($98M)Free cash flowFCF
n/m−483.1%−95.4%−47.7%Free cash flow marginFCF mgn
Balance sheet
$155M$381M$297M$130M$181MCash & investmentsCash+inv
$0$2M$39M$78M$81MReceivablesReceiv.
$0$1M$3M$6M$7MInventoryInvent.
$10M$13M$11M$5M$6MAccounts payablePayables
($10M)($10M)$31M$79M$81MOperating working capitalOper. WC
$161M$397M$360M$229M$277MCurrent assetsCur. assets
$26M$39M$86M$132M$125MCurrent liabilitiesCur. liab.
6.1×10.2×4.2×1.7×2.2×Current ratioCurr. ratio
$165M$414M$378M$259M$305MTotal assetsAssets
$95M$138M$201M$209M$164MTotal debtDebt
($60M)($244M)($96M)$79M($17M)Net debt / (cash)Net debt
-6.3×-4.0×-3.9×-2.3×-1.5×Interest coverageInt. cov.
($75M)($73M)($254M)($438M)($337M)Shareholders’ equityEquity
n/m43.5%16.4%14.0%Stock comp / revenueSBC/rev
Per share
39.1M51.3M63.2M72.9M82.1MShares out (diluted)Shares
$0.00$0.01$0.87$2.40$2.50Revenue / shareRev/sh
$-5.05$-3.93$-5.29$-3.03$-1.92EPS (diluted)EPS
$-3.76$-2.69$-4.22$-2.29$-1.19Owner earnings / shareOE/sh
$-3.77$-2.71$-4.22$-2.29$-1.19Free cash flow / shareFCF/sh
$0.03$0.03$0.00$0.00$0.00Cap. spending / shareCapex/sh
$-1.91$-1.42$-4.01$-6.01$-4.11Book value / shareBVPS

The record, charted

FY2022–2025

Each measure over its full record; the current point and the worst year marked.

Share count
73Mpeak FY2025
Gross margin
87%low FY2023

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

($167M)owner earningsvs.($221M)net incomelow FY2024

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned a $221M loss into ($167M) of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

FY2025FY2024FY2023FY2022
Reported net income($221M)($334M)($202M)($198M)
Depreciation & amortizationnon-cash charge added back+$633K+$795K+$575K+$620K
Stock-based compensationreal costnon-cash, but a real cost+$29M+$24M+$45M+$24M
Working capital & othertiming of cash in and out, other non-cash items+$25M+$43M+$18M+$26M
Cash from operations($167M)($267M)($138M)($147M)
Maintenance capital expenditurethe spending needed just to hold position and volume−$229K−$135K−$575K−$620K
Owner earnings($167M)($267M)($138M)($147M)
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−$1M−$421K
Free cash flow($167M)($267M)($139M)($148M)
Owner-earnings marginowner earnings ÷ revenue-95%-483%-20257%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $29M), owner earnings is nearer ($196M).

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Does not cover its interest
    Operating income ($160M) ÷ interest expense $68M
    What this means

    A full year of operating profit didn't cover the interest bill. This is the zombie zone: the business depends on refinancing, asset sales, or forbearance to service its debt.

  • Net debt against an operating loss
    Cash $130M − debt $209M
    What this means

    Netting $130M of cash and short-term investments against $209M of debt leaves $79M owed, with no operating profit this year to measure it against — understand that combination before anything else about the company. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 163 + DIO 89 − DPO 80 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Not meaningful here
    Invested capital ($359M) = debt $209M + equity ($438M) − cash
    Industry peers: median -64%
    What this means

    Invested capital is near zero or negative, usually years of buybacks pulling equity down. ROIC explodes or flips sign and stops meaning anything. Judge this one on Owner Earnings instead.

  • Consumes cash through the cycle
    3-yr median margin, range -20257%–-95%; latest ($167M) = operating cash ($167M) − maintenance capex $229K
    Industry peers: median -176%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -95% of revenue this year, a -483% median across 3 years. Treating stock comp as the real expense it is (less $29M of SBC) leaves ($196M).

  • Loss, and burning cash
    Net income ($221M) · cash from operations ($167M)
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did not.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 0.36×
    Harvesting
    Capex $229K ÷ depreciation $633K
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 0 of 3 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $175M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Near
    Current ratio ≥ 2× · 1.73×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $209M vs $97M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-3.16/share (latest year $-2.77), the averaged base the calculator's gate runs on, and book value is $-5.49/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2022–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 0 of 4
    What this means

    Lost money in 4 year(s), look at what happened there before trusting the average.

  • Operating margin −502% (median, 3 yrs)
    What this means

    Over the 3 years on record the operating margin has run around −502% — too short a record to call a through-cycle trend, but that is the level the business earns at.

  • Worst year 2023 · −24532.6% op. margin
    What this means

    Operations went underwater in 2023, understand why before trusting the good years.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$277M
  • Cash & short-term investments$181M
  • Receivables$81M
  • Inventory$7M
  • Other current assets$8M
Current liabilities$125M
  • Accounts payable$6M
  • Other current liabilities$119M
Current ratio2.21×all current assets ÷ what's due · Graham looked for 2×
Quick ratio2.16×stricter: inventory excluded
Cash ratio1.45×strictest: cash alone against what's due
Working capital$152Mthe cushion left after near-term bills
Cash runway1.9 yrsthe business is consuming cash; this is how long the cash on hand lasts at that rate
Revenue, latest quarter vs. a year ago+104.4%the freshest read on whether the business is still growing
Current ratio, recent quarters6.5× → 2.2×
Deeper floors
Tangible book value($337M)equity stripped of goodwill & intangibles
Net current asset value($366M)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$166M$3M of it operating leases
Deferred revenue$381Mcustomer cash collected before delivery; operating float

From the company's latest filing.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2023$3.4M$2.5M($138M)
2024$3.6M$3.8M($267M)
2025Mr. Basta$7.0M$24.4M($167M)
2025Ms. Curran$4.9M−$356k($167M)

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years. A dash under the name means the filing tags the figure without naming the officer.

  • Insider ownership9.3%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$29M

    The slice of the business handed to employees in shares this year, 16% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
AMRNAmarin Corporation plc$214M77%-24.3%-15%-18%
RYTMRhythm Pharmaceuticals Inc.$190M90%-238.1%-67%-176%
MRVIMaravai LifeSciences Holdings Inc.$186M53%16.8%-32%21%
STOKStoke Therapeutics Inc.$184M-559.3%-79%-254%
CYRXCryoPort Inc.$176M46%-44.0%-14%-17%
PHATPhathom Pharmaceuticals Inc.$175M86%-502.2%-483%
SNDXSyndax Pharmaceuticals Inc.$172M-3263.2%-64%-2251%
LQDALiquidia Corporation$158M76%-419.6%-163%-266%
Group median77%-328.9%-215%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Phathom Pharmaceuticals Inc. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.

$
The assumptions

Enter a price to run it.

Owner earnings it must reach
Margin the price demands
Owner-earnings margin today−48%

Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.

Cite: Owner Scorecard, "Phathom Pharmaceuticals Inc. (PHAT), the owner's record," https://ownerscorecard.com/c/PHAT, data as of 2026-07-09.

Manual order: ← PH its page in the Manual PHIN →

Industry order: ← PHAR the Pharmaceuticals chapter PRE →